UK-based pharmaceutical company AstraZeneca Plc (AZN) on Thursday disclosed that it has the capacity to produce 1 billion doses of its coronavirus vaccine should it prove to be successful. The stock rose 3.5% to $55.65 in pre-market U.S. trading.The drugmaker said it has signed first agreements for at least 400 million doses and has secured total manufacturing capacity for one billion doses of the potential vaccine, which it is developing with Oxford University. Start of deliveries are planned for September 2020, the company said in a statement.AstraZeneca is also working on entering into additional agreements supported by several parallel supply …read more
Source:: Yahoo Finance
